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ORIGINAL ARTICLE
1. Introduction1
In order to explore the effective method for the treatment 
of exudative tuberculous pleurisy, the application of cen-
tral venous catheter drainage and conventional thoracente-
sis for the treatment of exudative tuberculosis pleurisy had 
been compared in our department from September 2013 
to February 2015. The report was as follows.
2. Materials and methods
2.1. General information
60 cases of patients with exudative tuberculous pleurisy 
who were treated in the tuberculosis department at our 
hospital were selected from September 2013 to February 
2015 as the research subject. All the patients were diag-
nosed as exudative tuberculous pleurisy based on certain 
criteria such as the medical history, symptoms, signs, chest 
X-ray, chest CT, PPD skin test, tuberculosis antibody, pleu-
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ral effusion routine and biochemistry and so forth. After 
B-ultrasound examination, the patients were displayed in 
the middle amount of pleural effusion. The patients were 
comprised of 35 male and 25 female. Their age was be-
tween 17 to 74 years old, with the mean age was 45.5. The 
patients were divided into two groups namely, treatment 
and control group. The two groups were statistically com-
pared in terms of gender, age, pleural effusion volume and 
so on.
There was no significant difference in sex, age and the 
amount of pleural effusion between the two groups (p > 
0.05).
2.2. Treatment methodology
The treatment group was treated with central venous cath-
eter drainage. Generally patients were laid in a reverse sit-
ting position in order to determine the optimal surface 
puncture position of B-ultrasound. It is crucial for the 
puncture to get into the deepest of intercostal pleural ef-
fusion from seventh to ninth of infrascapular line as the 
puncture point in to the affected side. The disinfection 
procedures were carried out in accordance to conventional 
skin disinfection methods such as usage of sterile gloves 
with a laying aseptic hole-towel and 2% lidocaine hydro-
chloride. The needle was punctured in perpendicular to 
the upper edge of the rib at the puncture point. The anes-
thetic procedure was conducted by inserting the needle 
into the chest cavity until it reached the pleura. If there was 
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a breakthrough feeling occurrence and at the same time 
there was a liquid outflow during pumpback, it was the 
sign for the anesthesia needle to be pulled out. Then the 
needle with a Y type tube was punctured vertically into the 
chest cavity from the puncture point, meanwhile observ-
ing the liquid outflow during pumpback. Medical assistant 
guided along the Y type wire tube slowly into the chest for 
about 15 cm, and then the puncture needle was seceded. 
The wire tube was guided into the thoracic cavity to ex-
pand the skin, and then seceded for a while before the cen-
tral venous catheter was slowly introduced into the chest 
cavity along the guided wire. Generally in order to deter-
mine the pleural effusion outflow, the entering of the tubes 
into the chest was approximately 10−15 cm in length, and 
then the guided wire was seceded and the tube was closed. 
In order to fix the catheter with the applicator, the end of 
catheter was link with drainage bag, with the switch-on 
mode, and started the drainage process. The first drain-
age volume was less than 600 mL. However, daily drainage 
volume was less than 1000 mL soon after the first drainage 
process. If the pleural effusion could not be released, the 
pleural effusion disappeared or the amount of fluid became 
less after B-ultrasound examination was conducted. If the 
syringe was connected to the drainage tube, the pleural ef-
fusion could not be drawn out. Therefore, it was time to 
pull out the catheter [1,2].
The control group was treated with conventional thora-
centesis. After the conventional thoracic puncture under 
B-ultrasound examination, syringe with the specification 
of 50 mL was used in order to pump the liquid 2−3 times 
a week, in which, each puncture was located by B-ultra-
sound. The first drainage volume was less than 600 mL. 
Soon after that, the drainage was less than 1000 mL. The 
process was not finished until it could draw out the pleu-
ral effusion.
2.3. Observation index
Statistical analysis of the two groups were conducted by 
observing several parameters which include the absorption 
time of the pleural effusion, increment of pleural thick-
ness, the remission time of panting, and length of stay. 
Moreover, it was carried out in order to obtain the clinical 
comparison between the two groups of complications oc-
currence.
2.4. Efficacy evaluation criteria
Curative signs: Clinical symptoms disappeared and the 
pleural effusion completely disappeared. Excellence cura-
tive signs: The pleural effusion completely disappeared, 
lung functions recovered, and the costophrenic angle was 
visible. Effective curative signs: The pleural effusion was 
basically absorbed, with the liquid in the dark area was in 
the range of 0.5~2.0 cm and the costophrenic angle were 
slightly blunt. Invalid curative signs: None of the above cri-
teria was fulfilled. Total effective rate (%) = (Excellence + 
Effective)/Total number of cases × 100%.
2.5. Statistical analysis
In this study, all the data were processed by using SPSS 
18.0 statistical software, with “(x + s)” term to express the 
measurement data. T test was used for the comparison 
between the groups, and chi square test was used for the 
comparison of total effective rate. p < 0.01 indicated that it 
was statistically significant. 
3. Results
3.1. Clinical curative effect
Table 1 showed the comparison of clinical efficacy between 
the two groups. The clinical efficacy of the treatment group 
was significantly higher in contrast to the control group 
(p < 0.01). The crucial parameters in the pump volume of 
the two groups which includes pleural thickness, length of 
stay, and pulmonary function in the drainage process were 
significantly higher than that in the chest group. It was 
suggested that the method was beneficial for the drainage 
of pleural effusion. The pleural thickness was significantly 
lower in contrast to the puncture group (p < 0.05), while 
the average length of staying in the hospital was signifi-
cantly decreased.
Table 1. Comparison of efficacy between the two groups (n).





Treatment group 30 19 10 1 96.7%
Control group 30 13 10 7 76.7%
p value < 0.01
3.2. Adverse reactions effect
The comparison of adverse reactions between the two 
groups was shown in Table 2. The adverse reactions for 
the treatment group were less than the control group, and 
showed statistical significant difference (p < 0.01).
Table 2. Comparison of adverse reactions between the two 
groups (n).








Treatment group 30 1 1 1 10.0%
Control group 30 5 5 5 50.0%
p value < 0.01
The incidence of pectoralgia, infection and pleural re-
action in the treatment and control group was 3.3% and 
16.7%, respectively. The incidence of pneumothorax and 
pleural reaction in the puncture group was higher as com-
pared to the drainage group. The adverse reaction in the 
two groups was mild, and all of them showed improvement 
after the symptomatic treatment. All the selected cases in 
the drainage group were well tolerated with urokinase, 
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except for one patient who was experiencing mild pain af-
ter the injection. However, there was no special treatment 
and spontaneous remission, and it would not affect the 
continuity of the treatment. The clotting time of the pro-
thrombin and fibrinogen of the patients in the two groups 
revealed no differences either before or after treatment [3].
4. Discussions
Exudative tuberculous pleurisy is the pleural inflammation 
which is caused by mycobacterium tuberculosis and its 
metabolites by entering into the hypersensitive state pleu-
ral cavity of the body. In recent years, the incidence of exu-
dative tuberculous pleurisy has reinclined with the rapid 
rise of tuberculosis. In tuberculosis pleural effusion, the 
quantity of serum fibrin was high in amount, hence allow-
ing the formation of pachynsis pleurae adhesions [4]. Fi-
brin in tuberculosis pleural effusion were readily deposited 
in the pleural, hence forming the fibrous moss in order to 
close epipleural ostium lymphaticum, to thicken the ab-
sorbing film, and to hinder the resorption of pleural effu-
sion. If the pleural effusion persisted for a long time in the 
chest, the absorption function would become bad. Concur-
rently, it also increased the deposition rate of fibrin, so that 
the pleura became thicker and forming a vicious circle. 
The source of mycobacterium tuberculosis infection which 
causes exudative tuberculous pleurisy mainly includes: (1) 
Direct spreading: Pulmonary tuberculosis focus, dorsal 
phthisis, paravertebral abscess and thoracic tuberculosis 
could directly spread to the pleura; (2) Hematogenous dis-
semination: The bacteria of tuberculosis could represent 
themselves at any part of the body; (3) Lymphatic dis-
semination: Hilus of lung or tuberculosis of mediastinal 
lymph nodes, owing to lymphadenopathy was affected by 
lymphatic drainage process which lead to countercurrent 
of the lymph and pleura [5]. According to the domestic re-
ports, the tuberculosis pleural effusion accounts for about 
10% of tuberculosis. Exudative tuberculous pleurisy is 
mainly contributed to pleural allergic reaction, due to the 
high content of pleural effusion protein and is relatively 
easy to cause pleural adhesion, separation and inclusion, 
and affecting the lung function of the patients. Therefore, 
in the case of regular anti-tuberculosis treatment of exuda-
tive tuberculous pleurisy, pleural effusion should be either 
drained as soon as possible or inserted the tube for inter-
costal drainage in principle [6].
There are mainly three methods for the treatment of exu-
dative tuberculous pleurisy namely, (1) Relieve symptoms; 
(2) Elimination of the mycobacterium tuberculosis and pre-
vention of the disease occurrence; (3) Prevention of the 
formation of fibrothorax. The specific measurements were 
through regular anti-tuberculosis treatment, hormone and 
pleural effusion drainage treatment. Pleural effusion drain-
age treatment was the main measurement for male, which 
was conducted by controlling the pumping speed in order 
to drain once in a larger volume. Nonetheless, there were 
a lot of adverse reactions with low effective rate and other 
characteristics which sometimes reduplicated thoracente-
sis and subsequently contributed to patients’ intolerance 
psychologically and physiologically. In contrast to the tra-
ditional method of thoracentesis, the treatment of exu-
dative tuberculous pleurisy with central venous catheter 
drainage has several obvious advantages. (1) Operation 
became simpler except that during drainage, two persons 
were required to lay the catheter for the first time. After 
that, it can be handles by one person in order to complete 
the process quickly. This method significantly reduced 
the labor intensity of medical personnel and reserved the 
manpower. Besides, they have more time for other clinical 
works; (2) The number of puncture was reduced, therefore 
lessen the pain of patients in case of the patient needed to 
repeat the process again; (3) Central venous catheter has 
a small and soft diameter, hence the stimulation of the 
pleural was also small. There was no obvious pectoralgia, 
therefore, the patients had the likelihood to accept it easily; 
(4) Avoidance of the reduplicated puncture, which usually 
traumatized the patients. Complications such as infection, 
aerothorax, pleural reaction and so forth were lessened. 
The results of the treatment group showed that the clini-
cal curative effect was significantly higher in comparison 
to the control group (p < 0.01). The adverse reaction of the 
treatment group was less than that of the control group 
(p < 0.01). It indicated that application of central venous 
catheter drainage in the treatment of exudative tubercu-
lous pleurisy portrayed a favorable curative effect with less 
adverse reaction. It is worth to be promoted into the clini-
cal application. Tuberculosis pleural effusion is a common 
clinical disease and the pleural effusion often oppresses 
lung which limits the activity of the diaphragm, reduces 
respiratory area and lung capacity. Therefore, reduction 
of the pleural effusion and the complications incidence 
were mainly the key objectives for most of the clinicians. 
Clinical researches confirmed that central venous catheter 
closed drainage of thoracic cavity possessed high applica-
tion value in treating tuberculous pleural effusion. The 
study herein showed that absorption time of the pleural ef-
fusion in the treatment group was shorter than that in the 
control group. The pleural thickness, the remission time of 
panting, and duration of hospitalization for the treatment 
group was shorter in contrast to the control group. The 
total effective rate for the treatment of tuberculous pleural 
effusion was higher in the treatment group as compared 
to the control group. The incidence of complication was 
lower than that of the control group (p < 0.05). A few rel-
evant studies also showed that the traditional thoracentesis 
needed to be repeated that make the patients even suf-
fer. If the amount of pleural effusion was relatively small, 
pneumothorax and pleural reaction were rather easy to be 
eliminated. Central venous catheter closed drainage of tho-
racic cavity just need through checking of the chest once 
and the patients may experiencing less pain and are free 
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to have an activity concurrently. Central venous catheter 
closed drainage of thoracic cavity had less complications 
of pneumothorax and pleural reaction, which showed its 
high efficacy effect. The results of this study confirmed that 
the clinical effect of central venous catheter closed drain-
age of thoracic cavity to treat patients with pleural effusion 
was effective in comparison to the traditional paracentesis 
of chest provided that it should be strictly control during 
surgical process in order to avoid sustained shock, infec-
tion of puncture site, especially for the patients with severe 
disturbance of blood coagulation who were treated using 
this method. Additionally, the process of drainage should 
be in a uniform and slow speed with the control drainage 
speed of <50 mL/min and observed the patient’s condition 
continuously. When the patient appears to be sweating, 
having heart palpitations, face turned pale, experiencing 
dizziness and other adverse reactions, the drainage process 
should be stopped immediately and continued with symp-
tomatic treatment. In summary, central venous catheter 
closed drainage of thoracic cavity can be used in the treat-
ment of pleural effusion patients with the disappearance 
time of effusion was relatively short, and the incidence of 
complication was low. Moreover, the cost was lesser and 
duration of hospitalization was shorter with high efficacy 
effect. Therefore, it is worth be promoted further into the 
clinical applications.
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